Table 1. HMGB1 preys in HOSEpic and HPEpiC cells.
Gene | N | Cells | Function | Relation to cancer |
---|---|---|---|---|
ACBD3 | 7 | HOSEpiC | Apoptosis | Golgi resident protein GCP60 (GOCAP1) can interact with a golgin-160 fragment to regulate cell apoptosis [58]. |
C1QBP | 2 | HOSEpiC | Cell motility | C1qBP protects the cells against staurosporine induced apoptosis and increases proliferation and cell migration in cancerous cells [59]. Predictor of tumor size in progesterone positive tumors and marker for proliferation in breast cancer [60]. |
CCAR1 | 3 | HOSEpiC | Apoptosis | Cell division cycle and apoptosis regulator protein 1 (CARP-1) regulates cell growth and apoptosis by serving as a co-activator of several genes including steroid nuclear receptors and tumour suppressor p53 [49]. |
CTNNBL1 | 1 | HOSEpiC | Tumour progression | The spliceosome-associated factor, β-catenin-like protein 1, is overexpressed in high-grade serous ovarian carcinomas. Moreover, this protein can promote proliferation and invasion in ovarian cancer cells [29]. |
EIF1/SUI1 | 1 | HPEpiC | Apoptosis | Eukaryotic translation initiation factor 1 (eIF1) is activated by oncogene MCT-1 [61]. |
ENAH | 2 | HPEpiC | Cellular signalling | Protein enabled homolog. Involved in PI3K-dependent cell invasion induced by Platelet-derived growth factor in human breast cancer cells [62]. Involved in human lung cancer metastasis and migration of breast cancer cells [63]. |
FIP1L1 | 1 | HPEpiC | − | The fusion of the gene encoding the Pre-mRNA 3'-end-processing factor FIP, with the PDGFRA gene or the RARA gene generate a novel tyrosine kinase due to a interstitial chromosomal deletion [64]. These associations have been linked to the pathogenesis of leukemias [65]. |
HSPA5 | 1 | HOSEpiC | Tumour progression | 78 kDa glucose-regulated protein (GRP-78) or Heat shock 70 kDa protein 5 has been proposed as a potential biomarker for predicting high-risk endometrial carcinoma [66], as well as positive regulator of cellular migration [67]. |
KRT7 | 19 | HPEpiC | Cytoskeleton | Keratin, type II cytoskeletal 7. The keratin KRT7 gene has been found to be hyper-methylated in prostate cancer [33]. |
NEXN | 11 | HOSEpiC | Cytoskeleton Cell motility |
Nexilin is an F-actin associated protein that stimulates cell motility (Wang et al., 2005) and NEXN is down regulated after radiation of prostate adenocarcinoma cells [68]. |
PCOLCE | 1 | HOSEpiC | Tumour progression | Procollagen C-endopeptidase enhancer 1 (PCPE-1) binds procollagen, potentiating its cleavage by specific proteinases, and might be involved in tumour growth [69] . |
RPL29 | 2 | HOSEpiC | Tumour progression | 60S ribosomal protein L29 has been related to tumoral events as angiogenesis and cell proliferation [70]. |
RPS20 | 1 | HOSEpiC | Cellular signalling | 40S ribosomal protein S20 binds the RING-type E3 ubiquitin ligases Mdm2 and MdmX therefore regulating the Mdm2-p53-MdmX network [71]. |
SPINT1 | 2 | HPEpiC | Cellular signalling | Kunitz-type protease inhibitor 1 (or hepatocyte growth factor activator inhibitor type 1, HAI-1) malfunction promotes intestinal carcinogenesis by activating NF-κB signalling [72]. Low HAI-1 expression is a significant predictor for poor prognosis in prostate cancer [73]. |
UBE2I | 1 | HPEpiC | Tumour progression | SUMO-conjugating enzyme UBC9, plays a major role in sumoylation [74]. UBE2I expression is increased in several cancers as in epithelial ovarian cancer (EOC) [75], colon and prostate neoplasias and adenocarcinomas [76]. Moreover, overexpression of UBE2I has also been related to migration, invasion and proliferation in a lung cancer cell line [77] and in ovarian cancer [78] |
ZNF428 | 11 | HOSEpiC | Tumour progression | Zinc finger protein 428 interacts with Bcl2-associated athanogene 3 (BAG3) protein, which is related to cancerous processes. BAG3 can modulate apoptosis, autophagy, mechanotransduction, cytoskeleton organization, and motility [79]. Moreover, BAG3 regulates epithelial-mesenchymal transition (EMT) and angiogenesis and its knockdown reduced migration and invasion in cancerous cells [80]. |
N: repetitive identification during Y2H screening